//
//
EIC funding call for RNA-based therapies and diagnostics for rare genetic diseases

EIC funding call for RNA-based therapies and diagnostics for rare genetic diseases

The EIC Transition 2022 (HORIZON-EIC-2022-TRANSITION-01) call, which has opened on March 1st, is intended to meet the following specific objectives:

  1. Advance, beyond the state-of-the-art, RNA delivery methods, including robust mRNA formulations, that would enable effective and safe delivery of mRNA into the cells;
  2. Design, develop and preclinical validate of novel miRNAs (miRNA lncRNA, tRNA or siRNA-based) therapies for complex or rare genetic diseases;
  3. Develop and validate novel RNA-based diagnostics and RNA-based predictive biomarkers that would allow for early and more accurate diagnosis and for favourable or non- post-treatment prognosis, respectively.

For more information please visit EJP RD website.

Recent News

We are excited to share some great news! The third GEMSTONE ITC grant call is now open! In Grant Period 4, funding will be available for the Inclusiveness Target Countries...
Funding for MULTIPLE STSMs/ VM and ITC is available in Grant Period 4 and applications are highly encouraged! Application Deadline: 14.05.2023 For more information, please check the file below:
The Special Issue on “The Role of Nutrition in Osteoarthritis Development” of Nutrients (ISSN 2072-6643) (impact factor of 6.706), is now open for submission.  For more information, please check the link to the...
“BioGeMT Project – Recruitment of the Team which will support the ERA Chair holderThe ERA Chair Team for this project will involve the recruitment of:(i) Researchers to perform Bioinformatics research, data analysis,...
Iryna Khrystoforova has just finished her PhD at Bar-Ilan University, Azrieli Faculty of Medicine under supervision of Prof. Karasik, Genetics of musculoskeletal diseases lab. Currently she is a Postdoc at...
Ines Alves is the founder and president of ANDO Portugal, the Skeletal Dysplasia National Association as well as the representative of the European Patient Advocacy groups (ePAG) and many other...